European Sales and Marketing Expansion
SYDNEY, Australia, Wednesday 30th October 2019: Uscom Limited (ASX code: UCM) (the Company or Uscom) today announced the appointment of a new European Sales and Marketing Manager. Dr Antonio Ferrario will co-ordinate the newly established Uscom sales and marketing hub, based in Uscom Kft, Budapest, as it expands its reach from the UK, across Western and Central Europe, into Eastern Europe.
Dr Ferrario, a PhD in Biological Engineering, has more than 30 years experience in sales and marketing of medical devices, particularly in cardiovascular and pulmonary medicine, through dealers and directly into hospitals and clinics throughout Europe. Dr Ferrario has worked with Uscom for over 5 years in Italy and has successfully led the development of Uscom’s new Maternal Health market.
Dr Ferrario will start working with the new Hungarian sales team immediately to develop a new dealer led distribution model across Europe to increase sales volumes and margins for Uscom products. His expanded sales portfolio will now include all Uscom products: the USCOM 1A, the new BP+ and BP+ Reporter, and the SpiroSonic suite of devices. The new initiatives will include developing a major marketing initiative around the new Uscom SpiroSonic AIR and myAIR digital telemetric ultrasonic devices due for CE regulatory approval in the coming months.
The European Sales and Marketing hub in Budapest was established to expand Uscom’s customer support throughout Europe, and to expand the direct distribution of all Uscom products. Currently only the locally manufactured SpiroSonic devices are distributed through Uscom Kft.
Executive Chairman of Uscom, Associate Professor Rob Phillips said “The appointment of Dr Ferrario represents a strategic approach to increasing direct European sales. While China is strong for us, Europe and the US remain poor sales jurisdictions. Dr Ferrario’s experience with Uscom products and in the European market are a natural fit and logical next step for us to grow direct European sales. This expansion will be coupled with increased clinical and technical support from Uscom Kft to improve the experience of our customers. Europe remains a significant and wide-ranging specialist market requiring an often unique regional approach, and Antonio understands these nuances. We look forward to the revenue growth associated with Antonio’s activities as he applies his experience to build the European sales and marketing structure, particularly as the new AIR and myAIR products come to market.”
Uscom manufactures and markets the USCOM 1A, the Uscom BP+, and the Uscom SpiroSonic digital ultrasonic spirometry technologies. These premium digital devices are changing the way we diagnose and treat cardiovascular and pulmonary diseases. The USCOM 1A provides vital guidance for optimising management of sepsis and the administration of fluid, inotropes and vasoactive therapies in critical care monitoring. The BP+ SpiroSonic devices improve diagnosis and management of hypertension, heart failure, asthma, COPD and sleep disorders in the clinical and home care environments.